- Scheme Category:
- Equity Scheme >
- Sectoral/Thematic Funds
NAV: ₹ ↓ -0.53%
NAV chart
SMA (Simple Moving Average)
- 50 SMA
- 100 SMA
- 200 SMA
- 400 SMA
Returns
CAGR returns till date
CAGR returns of BAJAJ FINSERV HEALTHCARE FUND - DIRECT - GROWTH and its peers as on 1 October, 2026| Name | YTD | 1D | 1W | 1M | 3M | 1Y | 3Y | 5Y | 7Y | 10Y |
|---|---|---|---|---|---|---|---|---|---|---|
| BAJAJ FINSERV HEALTHCARE FUND - DIRECT - GROWTH | 19.77% | -0.53% | -3.73% | -4.25% | 5.68% | 20.97% | - | - | - | - |
| SBI CONSUMPTION OPPORTUNITIES FUND - DIRECT PLAN - GROWTH | -12.49% | -1.3% | -3.53% | -6.07% | -7.61% | -12.86% | 4.04% | 10.56% | 14% | 13.47% |
| SBI ESG Exclusionary Strategy Fund - Direct Plan -Growth | -8.41% | -0.51% | -2.15% | -6.2% | -4.8% | -4.64% | 7.63% | 7.46% | 11.9% | 11.24% |
| SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH | 20.71% | -0.29% | -3.55% | -3.34% | 2.86% | 20.19% | 22.83% | 17.78% | 26.13% | 14.6% |
| SBI INFRASTRUCTURE FUND - DIRECT PLAN - GROWTH | -2.81% | -1% | -2.42% | -3.71% | -6.43% | 0.48% | 11.75% | 15.13% | 18.63% | 15.01% |
| SBI COMMA Fund - DIRECT PLAN - Growth | 2.08% | -1.4% | -3.17% | -5.11% | -1.39% | 7.79% | 14.04% | 9.74% | 18.44% | 14.92% |
Discrete returns (yearly)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | - | - | - | - | - | - | - | - | - | -3.01% |
Discrete returns (monthly)
| Month | Dec 2025 | Jan 2026 | Feb 2026 | Mar 2026 | Apr 2026 | May 2026 | Jun 2026 | Jul 2026 | Aug 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | -1.91% | -5.29% | 3.07% | -4.3% | 8.07% | 4.62% | 5.89% | 5.65% | 5.61% | -3.74% |
Portfolio
Asset allocation
| Equity | Debt | Realestate | Commodities | Cash & Equivalents |
|---|---|---|---|---|
| 95.97% | 1.30% (Arbitrage: 0.00%) | 0.00% | 0.00% | 2.73% |
Equity
| Name | Symbol / ISIN | Sector | Weight % | Other links |
|---|---|---|---|---|
| Divi's Laboratories Limited | DIVISLAB (INE361B01024) | Pharmaceuticals & Biotechnology | 10.55% | |
| Sun Pharmaceutical Industries Limited | SUNPHARMA (INE044A01036) | Pharmaceuticals & Biotechnology | 8.21% | |
| Rubicon Research Limited | RUBICON (INE506V01022) | Pharmaceuticals & Biotechnology | 6.81% | |
| Piramal Pharma Limited | PPLPHARMA (INE0DK501011) | Pharmaceuticals & Biotechnology | 6.72% | |
| Aurobindo Pharma Limited | AUROPHARMA (INE406A01037) | Pharmaceuticals & Biotechnology | 6.18% | |
| Apollo Hospitals Enterprise Limited | APOLLOHOSP (INE437A01024) | Healthcare Services | 6.00% | |
| Torrent Pharmaceuticals Limited | TORNTPHARM (INE685A01028) | Pharmaceuticals & Biotechnology | 5.03% | |
| Neuland Laboratories Limited | NEULANDLAB (INE794A01010) | Pharmaceuticals & Biotechnology | 4.11% | |
| Emcure Pharmaceuticals Limited | EMCURE (INE168P01015) | Pharmaceuticals & Biotechnology | 3.84% | |
| Max Healthcare Institute Limited | MAXHEALTH (INE027H01010) | Healthcare Services | 3.35% | |
| Fortis Healthcare Limited | FORTIS (INE061F01013) | Healthcare Services | 2.69% | |
| Zydus Lifesciences Limited | ZYDUSLIFE (INE010B01027) | Pharmaceuticals & Biotechnology | 2.56% | |
| IPCA Laboratories Limited | IPCALAB (INE571A01038) | Pharmaceuticals & Biotechnology | 2.46% | |
| Laurus Labs Limited | LAURUSLABS (INE947Q01028) | Pharmaceuticals & Biotechnology | 2.36% | |
| Vijaya Diagnostic Centre Limited | VIJAYA (INE043W01024) | Healthcare Services | 2.31% | |
| Zydus Wellness Limited | ZYDUSWELL (INE768C01028) | Food Products | 2.27% | |
| Senores Pharmaceuticals Limited | SENORES (INE0RB801010) | Pharmaceuticals & Biotechnology | 2.15% | |
| Shaily Engineering Plastics Limited | SHAILY (INE151G01028) | Consumer Durables | 2.00% | |
| GlaxoSmithKline Pharmaceuticals Limited | GLAXO (INE159A01016) | Pharmaceuticals & Biotechnology | 1.79% | |
| Glenmark Pharmaceuticals Limited | GLENMARK (INE935A01035) | Pharmaceuticals & Biotechnology | 1.70% | |
| Dr. Lal Path Labs Limited | LALPATHLAB (INE600L01024) | Healthcare Services | 1.68% | |
| Sanofi Consumer Healthcare India Limited | SANOFICONR (INE0UOS01011) | Pharmaceuticals & Biotechnology | 1.41% | |
| Cipla Limited | CIPLA (INE059A01026) | Pharmaceuticals & Biotechnology | 1.39% | |
| Dr. Reddy's Laboratories Limited | DRREDDY (INE089A01031) | Pharmaceuticals & Biotechnology | 1.28% | |
| Biocon Limited | BIOCON (INE376G01013) | Pharmaceuticals & Biotechnology | 1.16% | |
| Navin Fluorine International Limited | NAVINFLUOR (INE048G01026) | Chemicals & Petrochemicals | 0.99% | |
| Krishna Institute Of Medical Sciences Limited | KIMS (INE967H01025) | Healthcare Services | 0.93% | |
| Turtlemint Fintech Solutions Limited | (INE0OC301013) | Financial Technology (Fintech) | 0.92% | |
| Onesource Specialty Pharma Limited | ONESOURCE (INE013P01021) | Pharmaceuticals & Biotechnology | 0.82% | |
| Medi Assist Healthcare Services Limited | MEDIASSIST (INE456Z01021) | Insurance | 0.82% | |
| Jubilant Pharmova Limited | JUBLPHARMA (INE700A01033) | Pharmaceuticals & Biotechnology | 0.76% | |
| MTAR Technologies Limited | MTARTECH (INE864I01014) | Electrical Equipment | 0.26% | |
| Sumitomo Chemical India Limited | SUMICHEM (INE258G01013) | Fertilizers & Agrochemicals | 0.25% | |
| Neogen Chemicals Limited | NEOGEN (INE136S01016) | Chemicals & Petrochemicals | 0.21% |
Debt
| Name | Isin | Rating | Weight % | Yield |
|---|---|---|---|---|
| Bajaj Finserv Money Market Fund-Direct Plan-Growth | INF0QA701334 | 1.30% | % |
Portfolio data is as on date 31 August, 2026
NAV history
BAJAJ FINSERV HEALTHCARE FUND - DIRECT - GROWTH - 30 days NAV (Net asset value) history
| Date | NAV | % change |
|---|---|---|
| 1 October, 2026 | 11.734 | -0.53% |
| 30 September, 2026 | 11.797 | -1.69% |
| 29 September, 2026 | 12.000 | -0.07% |
| 28 September, 2026 | 12.008 | -1.19% |
| 25 September, 2026 | 12.153 | -0.3% |
| 24 September, 2026 | 12.189 | -1.09% |
| 23 September, 2026 | 12.323 | 0.95% |
| 22 September, 2026 | 12.207 | -0.94% |
| 21 September, 2026 | 12.323 | 0.56% |
| 18 September, 2026 | 12.254 | 0.8% |
| 17 September, 2026 | 12.157 | 1.18% |
| 16 September, 2026 | 12.015 | -0.57% |
| 15 September, 2026 | 12.084 | -1.47% |
| 11 September, 2026 | 12.264 | -0.21% |
| 10 September, 2026 | 12.290 | -0.36% |
| 9 September, 2026 | 12.335 | -0.76% |
| 8 September, 2026 | 12.429 | 1.47% |
| 7 September, 2026 | 12.249 | 0.94% |
| 4 September, 2026 | 12.135 | -0.48% |
| 3 September, 2026 | 12.194 | -0.27% |
| 2 September, 2026 | 12.227 | -0.23% |
| 1 September, 2026 | 12.255 | -1.07% |
| 31 August, 2026 | 12.388 | 0.52% |
| 28 August, 2026 | 12.324 | 0.27% |
| 27 August, 2026 | 12.291 | 0.82% |
| 26 August, 2026 | 12.191 | 0.91% |
| 25 August, 2026 | 12.081 | 0.42% |
| 24 August, 2026 | 12.030 | -0.1% |
| 21 August, 2026 | 12.042 | -0.5% |
| 20 August, 2026 | 12.103 |
FAQ (Frequently asked questions)
What is latest/current NAV/price of BAJAJ FINSERV HEALTHCARE FUND - DIRECT - GROWTH?
The latest NAV of BAJAJ FINSERV HEALTHCARE FUND - DIRECT - GROWTH is 11.734 as on 1 October, 2026.What are YTD (year to date) returns of BAJAJ FINSERV HEALTHCARE FUND - DIRECT - GROWTH?
The YTD (year to date) returns of BAJAJ FINSERV HEALTHCARE FUND - DIRECT - GROWTH are 19.77% as on 1 October, 2026.What are 1 year returns of BAJAJ FINSERV HEALTHCARE FUND - DIRECT - GROWTH?
The 1 year returns of BAJAJ FINSERV HEALTHCARE FUND - DIRECT - GROWTH are 20.97% as on 1 October, 2026.What are top 10 holdings of BAJAJ FINSERV HEALTHCARE FUND - DIRECT - GROWTH?
Top 10 holdings of BAJAJ FINSERV HEALTHCARE FUND - DIRECT - GROWTH are:- Divi's Laboratories Limited
- Sun Pharmaceutical Industries Limited
- Rubicon Research Limited
- Piramal Pharma Limited
- Aurobindo Pharma Limited
- Apollo Hospitals Enterprise Limited
- Torrent Pharmaceuticals Limited
- Neuland Laboratories Limited
- Emcure Pharmaceuticals Limited
- Max Healthcare Institute Limited
- Fortis Healthcare Limited
What is LTCG (Long term capital gain) and STCG (Short term capital gain) tax for BAJAJ FINSERV HEALTHCARE FUND - DIRECT - GROWTH?
BAJAJ FINSERV HEALTHCARE FUND - DIRECT - GROWTH is equity oriented mutual fund. Various capital gain taxes are applicable as below (Effective for redemption after July 23, 2024 and from FY 2024-25)Holding period Tax rate Less than 1 year (STCG) 20% More than 1 year (LTCG) Tax free upto Rs. 1.25 lakhs. 12.5% on rest amount.